Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?

Interactive Cardiovascular and Thoracic Surgery

Volumn 7, Issue 3, 2008, Pages 470-475

  Raja, Shahzad G ^a   Fida, Naveed ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensin II receptor blockers; Cardiac surgery; Evidence based medicine; Systemic vascular resistance

Indexed keywords

ADRENALIN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; CATECHOLAMINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; FENTANYL; HEPARIN; HYPERTENSIVE FACTOR; INOTROPIC AGENT; METARAMINOL; MIDAZOLAM; NORADRENALIN; PHENYLEPHRINE; PLACEBO; QUINAPRIL; RENIN; VASOACTIVE AGENT;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE CONTROL STUDY; CATECHOLAMINE BLOOD LEVEL; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; EVIDENCE BASED MEDICINE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART SURGERY; HUMAN; HYPERTENSION; HYPOTENSION; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; MITRAL VALVE REPLACEMENT; OUTCOME ASSESSMENT; PERICARDIOTOMY; PLASMA RENIN ACTIVITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SHOCK; VASCULAR RESISTANCE; VASODILATATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENCHMARKING; CARDIAC SURGICAL PROCEDURES; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; VASCULAR DISEASES; VASCULAR RESISTANCE; VASODILATION;

EID: 44449178834     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2007.174698     Document Type: Article

References (12)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-409.
2. Lee YK, Na SW, Kwak YL, Nam SB. Effect of pre-operative angiotensin-converting enzyme inhibitors on haemodynamic parameters and vaso-constrictor requirements in patients undergoing off-pump coronary artery bypass surgery. J Int Med Res 2005;33:693-702.
3. Devbhandari MP, Balasubramanian SK, Codispoti M, Nzewi OC, Prasad SU. Preoperative angiotensin-converting enzyme inhibition can cause severe post CPB vasodilation - current UK opinion. Asian Cardiovasc Thorac Ann 2004;12:346-349.
4. Bertrand M, Godet G, Meersschaert K, Brun L, Salcedo E, Coriat P. Should the angiotensin II antagonists be discontinued before surgery? Anesth Analg 2001;92:26-30.
5. Mekontso-Dessap A, Houël R, Soustelle C, Kirsch M, Thébert D, Loisance DY. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 2001;71:1428-1432.
6. Carrel T, Englberger L, Mohacsi P, Neidhart P, Schmidli J. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg 2000;15:347-353.
7. Pigott DW, Nagle C, Allman K, Westaby S, Evans RD. Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth 1999;83:715-720.
8. Boeken U, Feindt P, Mohan E, Zimmermann N, Micek M, Kalweit G, Gams E. Post-perfusion syndrome and disturbed microcirculation after cardiac surgery: the role of angiotensin-converting-enzyme inhibitors. Thorac Cardiovasc Surg 1999;47:347-351.
9. Webb CM, Underwood R, Anagnostopoulos C, Bennett JG, Pepper J, Lincoln C, Collins P. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery - a randomised study. Eur J Cardiothorac Surg 1998;13:42-48.
10. Deakin CD, Dalrymple-Hay MJ, Jones P, Monro JL. Effects of angiotensin converting enzyme inhibition on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 1998;13:546-550.
11. Licker M, Neidhart P, Lustenberger S, Valloton MB, Kalonji T, Fathi M, Morel DR. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology 1996;84:789-800.
12. Tuman KJ, McCarthy RJ, O'Connor CJ, Holm WE, Ivankovich AD. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995;80:473-479.